CLS vs FLEX: Which Is the Better Buy in 2026?

Last updated November 2026

Short answer

CLS (Celestica) and FLEX (Flex Ltd) share investment themes but are different businesses. The right pick is whichever thesis you actually believe, sized so you are not over-concentrated in one theme.

CLS vs FLEX: the tie-breaker metrics

Same yardstick, side by side (as of November 2026). Valuation lined up like this is most meaningful for two names in the same corner of the market, which these are. Figures are approximate; verify before investing.

MetricCLSFLEXWhat it tells you
Market cap$28.57B$27.91BSize. The larger name is the incumbent; the smaller has more room to grow and more to prove.
Forward P/E10.199.71Valuation on next year's expected earnings, the same yardstick for both. Lower is cheaper for that growth; higher means the market is paying up.
Trailing P/E21.3727.18Valuation on the last 12 months. A big drop from trailing to forward means the market expects earnings to jump, so more growth is already in the price.
Beta1.351.79Volatility vs the market. Above 1 swings harder than the index; below 1 is steadier. Higher beta means bigger drawdowns to hold through.
Price vs 52-week range10% of range20% of rangeWhere today's price sits between the 52-week low and high. Near the high is momentum with less margin of safety; near the low is out of favor or a discount, depending on why.
Price / book4.604.81How much you pay over book value. Very high can signal an asset-light, high-return business or a rich price.

Before you buy: how CLS and FLEX affect your concentration

The metrics above tell you which is the marginally better business. The bigger risk for most people is not picking the slightly worse stock, it is over-concentrating. CLS and FLEX share themes, so owning both, or adding either to what you already hold, can quietly push a large share of your portfolio into one bet.

This is the part a generic comparison page cannot answer, because it depends on what you own. Connect your brokerage and Walnut shows your real, combined CLS and FLEX exposure, flags overlap with your existing positions, and tells you if adding one would tip you past a concentration you are comfortable with, read-only by default, with your login staying at your broker. Walnut is not an investment adviser.

What does Celestica (CLS) do?

Celestica is a Toronto-based electronics manufacturing services (EMS) and supply-chain company that designs, builds, and tests hardware for other companies. It reports in two segments. Connectivity & Cloud Solutions (CCS) is the larger and faster-growing one, serving data-center and communications customers with networking switches, servers, storage, and increasingly custom AI/ML compute hardware; in Q1 2026 CCS was about ~80% of total revenue and grew roughly ~76% year over year, with hyperscaler customers making up the majority of that segment. Advanced Technology Solutions (ATS) is the diversified segment covering aerospace and defense, industrial, HealthTech, and capital equipment. The company makes money on the volume and complexity of the hardware it manufactures and on higher-value design and joint-design-manufacturing (JDM) work, where margins are structurally better than commodity contract assembly.

Full CLS guide

What does Flex Ltd (FLEX) do?

Flex Ltd is a global electronics manufacturing services (EMS) company, effectively an outsourced factory and supply chain that designs and builds products for other brands. It is consistently ranked among the largest EMS providers in the world by revenue, competing near the top of the industry with fiscal-year revenue of about $27.9 billion for the year ended March 2026 and about $29.3 billion over the trailing twelve months. Flex reports across segments including Flex Agility Solutions and Flex Reliability Solutions, serving end markets that span cloud and data-center infrastructure, automotive, industrial, healthcare, and energy. Because it manufactures on contract, its margins are structurally thin compared with the brands it serves, and the investment case turns on volume, efficiency, and moving into higher-value services like design, power products, and data-center integration.

Full FLEX guide

CLS vs FLEX: how do they differ?

Both fit overlapping themes, but they are not interchangeable. The useful comparison is which set of drivers and risks you want exposure to.

  • CLS drivers: Hyperscaler-driven CCS growth; AI networking and compute content.
  • FLEX drivers: Data-center and AI infrastructure demand; Margin-mix shift toward higher-value work.

Which fits which kind of investor

A faster-growing, richer-valued name usually swings harder, so it suits a longer horizon and a higher tolerance for volatility; a steadier, more cash-generative business suits a more conservative or income-minded investor. A useful test is which set of risks you could hold through a drawdown: Customer concentration is the headline risk: as of Q1 2026 three customers each represented at least 10% of revenue (roughly 35%, 15%, and 15%), and the top ten customers made up about ~78% of revenue, so losing or being de-prioritized by a single hyperscaler would matter a lot. For FLEX, the dominant risk is that EMS is a low-margin, high-volume business, so thin margins leave little room for error and any operational stumble or pricing pressure hits profit quickly.

CLS or FLEX: which should you pick?

Pick CLS if you believe its drivers more; FLEX if you believe its. Many investors hold both, but since they share themes, that is a concentrated bet, not diversification. Decide deliberately and check overlap. For the full detail, see the CLS and FLEX guides.

CLS vs FLEX: the full fundamentals

CLS. At about 32 times trailing and 16 times forward earnings as of October 16, 2026, Celestica trades at a much lower multiple than in mid-2026, because the share price has drifted while earnings estimates kept rising (analysts expect 2027 EPS near $19.36, up about 76%). The 18-analyst mean target of about $474 sits far above the $306.83 close, with a consensus of strong buy. A premium-to-history multiple still leaves the stock sensitive to any sign that hyperscaler AI spending is slowing, and the October 26 Q3 report is the next test.

FLEX. Flex trades near 36 times trailing GAAP earnings but about 13 times forward estimates, which assume data-center growth lifts EPS sharply over the next two fiscal years. The valuation debate is now about the pieces: what the remaining EMS business and the spun-off Axiom are each worth, and whether the preferred-stock terms dilute that value. Goldman Sachs trimmed its target to $145 from $154 on October 16; figures are as of that date and change daily.

Headline figures (approximate, October 2026): CLS shows revenue (ttm) ~$15.6B, q2 2026 revenue ~$4.7B (up ~62% YoY), q2 2026 adjusted eps $2.54 vs $2.31 estimate, net income (ttm) ~$1.12B (~7.2% net margin); FLEX shows revenue (ttm) ~$29.3 billion; up ~21% year over year in the quarter ended June 26, 2026 (~$7.48 billion), margins (ttm) gross ~9.5%, operating ~5%, net ~3.3%, net income (ttm) ~$973 million, eps latest quarter $1.00 vs ~$0.92 consensus; FY ending March 2027 consensus ~$4.71.

The bottom line: CLS vs FLEX

CLS and FLEX are related but distinct: same themes, different businesses and risks. Neither wins in the abstract; the right pick is whichever thesis you actually believe, sized so you are not over-concentrated in one theme. Walnut can show your combined CLS and FLEX exposure against your real portfolio. It is not an investment adviser.

Wondering how CLS or FLEX fits the portfolio you already own? Walnut is an AI investing app that connects your brokerage read-only and answers questions like that about your actual holdings: overlap, concentration, and how each position tracks the S&P 500. Compare the best AI portfolio analyzers or see the best AI investing apps in 2026.

Your questions about Celestica

Ask Walnut's AI anything about CLS and see how it fits what you own.

FAQ

What is the difference between CLS and FLEX?

+

Celestica is a Toronto-based electronics manufacturing services (EMS) and supply-chain company that designs, builds, and tests hardware for other companies. Flex Ltd is a global electronics manufacturing services (EMS) company, effectively an outsourced factory and supply chain that designs and builds products for other brands. They show up together because they share investment themes, but they are different businesses, so the better fit depends on which thesis you are expressing.

Is CLS or FLEX the better stock?

+

Neither is universally better; they suit different views and risk levels. Walnut is informational, not investment advice. Compare what each does, the tie-breaker metrics above, and the risks, then decide which fits your thesis and what you already own.

Which is cheaper, CLS or FLEX?

+

On forward P/E (as of November 2026), CLS trades at 10.19x and FLEX at 9.71x, so FLEX is the cheaper of the two on next year's expected earnings. A lower multiple is not automatically the better buy: a richer valuation can be justified by faster growth, and a lower one can reflect real risk. Weigh the multiple against how fast each business is compounding.

Should you own both CLS and FLEX?

+

Because they share themes, owning both concentrates you in that theme. That can be intentional (a focused bet) or accidental (less diversification than it looks). Walnut can show your combined exposure across both, and whether adding either over-concentrates you, before you buy.

What are the risks of CLS vs FLEX?

+

CLS: Customer concentration is the headline risk: as of Q1 2026 three customers each represented at least 10% of revenue (roughly 35%, 15%, and 15%), and the top ten customers made up about ~78% of revenue, so losing or being de-prioritized by a single hyperscaler would matter a lot. EMS has historically run thin margins, leaving limited cushion if pricing or volumes compress. The business is tied to AI capital spending, which is cyclical and could slow or pause after a heavy buildout phase. And the stock has re-rated to a much higher multiple than its EMS history, so it carries both competition from Jabil, Flex, Foxconn, and ODMs and the risk that high growth expectations are not met. The stock has already shown that sensitivity: it fell from a 52-week high near $474 to about $307 by October 16, 2026 during a summer pullback in AI-capex sentiment, even as quarterly results kept beating estimates. Walnut is not an investment adviser; this page describes the company and is not a recommendation. FLEX: The dominant risk is that EMS is a low-margin, high-volume business, so thin margins leave little room for error and any operational stumble or pricing pressure hits profit quickly. Customer concentration is a structural risk: losing or seeing a slowdown at a few large customers can materially dent revenue. Flex is exposed to the broader electronics and manufacturing cycle, so a downturn in demand across cloud, automotive, or industrial markets would pressure volumes. As a global manufacturer, it faces tariff, trade-policy, and supply-chain risks, including component shortages and the cost of shifting production across regions. The data-center tailwind is powerful but also a concentration bet: if hyperscaler capital spending on AI infrastructure slows, a big source of recent upside could fade. Finally, contract manufacturers have limited pricing power against the brands they serve, which caps how much margin expansion is realistically achievable. The planned Axiom spin-off adds new risks: execution and timing of the separation, the obligations attached to the $2 billion preferred (a 10% cash dividend before separation and a premium redemption guaranteed by Flex if the deal slips past December 31, 2027), and the reduced growth profile of the remaining EMS business. The stock's roughly 27% drop over three months shows how sharply sentiment can swing on these questions.

Walnut is informational, not investment advice. This page is descriptive and not a recommendation to buy or sell CLS or FLEX; figures are approximate and dated (as of November 2026). Verify current data before investing.